This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.

Social Media Links

| less than a minute read

Indian Pharma Companies Should Aim to Become the Global Benchmark of Quality

Amit Jaju shares how Ankura's automated solution- Early Warning System (EWS) can be leveraged by Indian pharma companies to navigate the regulatory landscape in regulated market in this Indian Pharma Post interview. Our data and technology expert discusses the contemporary and regulatory challenges faced by the Indian Pharma industry and shares his take on digitization and automation, data integrity, and compliance issues faced by the "pharmacy of the world" as the Indian pharma industry moves towards Industry 4.0.

Read the full article here.

© Copyright 2022. The views expressed herein are those of the author(s) and not necessarily the views of Ankura Consulting Group, LLC., its management, its subsidiaries, its affiliates, or its other professionals. Ankura is not a law firm and cannot provide legal advice.

For India to be called ‘quality pharma’, Indian pharma companies should aim to become the global benchmark of quality [...] creating a mindset that everybody in the organization, not just the quality controllers, is responsible for quality.

Tags

data & technology, article, f-risk, healthcare & life sciences

Let’s Connect

We solve problems by operating as one firm to deliver for our clients. Where others advise, we solve. Where others consult, we partner.

I’m interested in

I need help with